Nd revising on the manuscript. A.K.: Surgeon on a lot of of your instances, involved in drafting and revising in the manuscript. L.H.L.: Oncologist. Each and every patient was discussed inside the interdisciplinary panel along with the decision to treat was depending on this, involved in drafting and revising of your manuscript. S.N.: Reviewing the radiotherapy and deciding which patient to treat or not to treat, involved in drafting and revising on the manuscript. T.K.: Pathologist reviewing the pathologic investigations, involved in drafting and revising on the manuscript. C.B.: Assistant surgeon on numerous of your cases, reviewer of the manuscript, involved in drafting and revising of the manuscript. A.B.-M.: Radiologist reviewing the radiologic investigations, involved in drafting and revising from the manuscript. H.R.D.: Corresponding author. Created the study notion, did the final information analysis and offered the big clinical input in writing and revising of the manuscript. Attending surgeon specialized in Orthopedic Oncology. Each author has contributed significantly to, and is prepared to take public responsibility for this study: its design and style, information acquisition, and analysis and interpretation of information. All authors have study and agreed towards the published version of your manuscript. Funding: This research received no external funding. Institutional Evaluation Board Statement: This study was approved by the ethics committee of your Medical Faculty, D-Fructose-6-phosphate disodium salt Epigenetic Reader Domain University of Munich (17-891, February 2018). Informed Consent Statement: Informed consent was obtained from all surviving sufferers integrated in this study. For non-surviving individuals, information were irreversibly anonymized, as advisable by the ethics committee. Data Availability Statement: The datasets applied and/or analyzed through the present study are out there from the corresponding author on reasonable request. Conflicts of Interest: All authors have no monetary and personal relationships with other persons or organizations that could inappropriately influence (bias) this work.AbbreviationsAI: Adriamycin and Ifosfamid; CTX: chemotherapy; CT: computed tomography; DFS: illness free of charge survival; EIA: Etoposid, Ifosamid and Adriamycin; ESMO: European Society of Healthcare Oncology; FNCLCC: F ation Nationale des Centres de Lutte Contre le Cancer; G1, G2, G3: Grading in line with the French Federation of 11-Aminoundecanoic acid Autophagy Cancer Centers grading technique; Gy: Gray; LR: local recurrence; LRFS: neighborhood recurrence free of charge survival; MRI: Magnetic resonance imaging; NCCN: National Complete Cancer Network; NIH: National Institute of Health; n.s.: not important; R0, R1, R2: resection margin; RTX: radiotherapy; OS: general survival; STS: soft tissue sarcomas; TMCC: Toronto Margin Context Classification; UICC: Union internationale contre le cancer.
agronomyArticleThe Productivity of Cassava (Manihot esculenta Crantz) in Kagoshima, Japan, Which Belongs towards the Temperate ZoneShin Yabuta 1 , Tamami Fukuta 1 , Shotaro Tamaru 2 , Keita Goto two , Yoshihiro Nakao 1 , Phanthasin Khanthavong two,three , Peter Ssenyonga four,5 and Jun-Ichi Sakagami 1, 3Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan; [email protected] (S.Y.); [email protected] (T.F.); [email protected] (Y.N.) The United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; [email protected] (S.T.); [email protected] (K.G.); [email protected] (P.K.) National Agriculture and Forestry Study Institute, Vientiane 7170, Laos Graduate Sch.
